483 Vertex Pharmaceuticals Sep 2016

483 Vertex Pharmaceuticals Sep 2016

$119 - Not in Stock

FDA investigators audited the Vertex Pharmaceuticals - Boston, MA, United States facility and issued inspectional observations (via FDA 483) on 21 Sep 2016.

Product details

  • Category: Human Drugs
  • Inspection end: 21 Sep 2016
  • Location: Boston, United States
  • FEI: 1000513211
Order